Comparison of the Acute Rejection Incidence Rate in Spousal Donor Transplantation Before and After Anti-CD20 Antibody (Rituximab) Protocol as Desensitization Therapy-Reference-Cited by-同舟云学术

Comparison of the Acute Rejection Incidence Rate in Spousal Donor Transplantation Before and After Anti-CD20 Antibody (Rituximab) Protocol as Desensitization Therapy

Published:2011-01-27 Issue:1 Volume:15 Page:89-97
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:

Author:

Hirai Toshihito,Ishida Hideki,Toki Daisuke,Miyauchi Yuuki,Kohei Naoki,Iida Shouichi,Tokita Daisuke,Shimizu Tomokazu,Shirakawa Hiroki,Omoto Kazuya,Tanabe Kazunari

Publisher

Wiley

Subject

Nephrology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1744-9987.2010.00856.x/fullpdf

Reference31 articles.

1. Long-term results of living unrelated renal transplantation;Ishikawa;Transplant Proc,1999

2. Increased rejection in living unrelated vs. living related kidney transplants does not affect short-term function and survival;Fuller;Transplantation,2004

3. Increased acute rejection episodes among recipients of living unrelated donor compared with cadaver and living related donor renal transplants;Long;Transplant Proc,2002

4. Long-term graft outcome of living donor renal transplantation: single center experience;Kwon;Transplant Proc,2005

5. Study of the effect of donor source on graft and patient survival in pediatric renal transplant recipients;Gheith;Pediatr Nephrol,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher Donor Age and Severe Microvascular Inflammation Are Risk Factors for Chronic Rejection After Treatment of Active Antibody-Mediated Rejection;Transplant International;2024-02-02

2. Desensitization Regimen Consisting of High-Dose Intravenous Immunoglobulin, Plasmapheresis, and Rituximab (an Anti-CD20 Antibody), Without Eculizumab and/or Bortezomib, in 41 Highly Sensitized Kidney Transplant Recipients;Experimental and Clinical Transplantation;2021-10

3. Single antigen testing to reduce early antibody-mediated rejection risk in female recipients of a spousal donor kidney;Transplant Immunology;2021-08

4. Transitional B Cells Predominantly Reconstituted After a Desensitization Therapy Using Rituximab Before Kidney Transplantation;Therapeutic Apheresis and Dialysis;2017-03-13

5. Analysis of Predictive and Preventive Factors for De Novo DSA in Kidney Transplant Recipients;Transplantation;2014-08-27